This company has been acquired
The company may no longer be operating, as it has been acquired. Find out why through their latest events.
Sharps Compliance Zukünftiges Wachstum
Future Kriterienprüfungen 3/6
Wichtige Informationen
55.0%
Wachstumsrate der Gewinne
52.1%
EPS-Wachstumsrate
| Healthcare Gewinnwachstum | 17.0% |
| Wachstumsrate der Einnahmen | 5.1% |
| Zukünftige Eigenkapitalrendite | n/a |
| Analystenabdeckung | Low |
| Zuletzt aktualisiert | n/a |
Jüngste Aktualisierungen zum künftigen Wachstum
Recent updates
Aurora Capital Partners affiliate to acquire Sharps Compliance for $8.75 per share
Jul 12We Like These Underlying Return On Capital Trends At Sharps Compliance (NASDAQ:SMED)
Jul 02
Is Sharps Compliance (NASDAQ:SMED) Using Too Much Debt?
Jun 13Sharps Compliance Corp.'s (NASDAQ:SMED) Shareholders Might Be Looking For Exit
May 25Here's Why I Think Sharps Compliance (NASDAQ:SMED) Might Deserve Your Attention Today
May 03Sharps Compliance: Update Prior To Important Earnings
Apr 26Sharps Compliance: An Operator In The Medical Waste Industry
Jan 04Is Sharps Compliance (NASDAQ:SMED) Using Too Much Debt?
Dec 06Time To Worry? Analysts Just Downgraded Their Sharps Compliance Corp. (NASDAQ:SMED) Outlook
Aug 20These 4 Measures Indicate That Sharps Compliance (NASDAQ:SMED) Is Using Debt Reasonably Well
Jun 18Sharps Compliance: Undervalued, Even If Growth Returns To Historical Levels
Jun 04With EPS Growth And More, Sharps Compliance (NASDAQ:SMED) Is Interesting
May 20Are Investors Undervaluing Sharps Compliance Corp. (NASDAQ:SMED) By 39%?
May 07Sharps Compliance EPS beats by $0.27, beats on revenue
Apr 28What Type Of Shareholders Own The Most Number of Sharps Compliance Corp. (NASDAQ:SMED) Shares?
Mar 15Has Sharps Compliance (NASDAQ:SMED) Got What It Takes To Become A Multi-Bagger?
Mar 01Upgrade: Analysts Just Made A Substantial Increase To Their Sharps Compliance Corp. (NASDAQ:SMED) Forecasts
Feb 02Earnings Beat: Sharps Compliance Corp. Just Beat Analyst Forecasts, And Analysts Have Been Updating Their Models
Feb 01Is Sharps Compliance (NASDAQ:SMED) Weighed On By Its Debt Load?
Jan 26Sharps Compliance reports robust order activity
Jan 11Is There An Opportunity With Sharps Compliance Corp.'s (NASDAQ:SMED) 33% Undervaluation?
Jan 05
Don't Ignore The Fact That This Insider Just Sold Some Shares In Sharps Compliance Corp. (NASDAQ:SMED)
Dec 18Shareholders Are Thrilled That The Sharps Compliance (NASDAQ:SMED) Share Price Increased 117%
Dec 07Is Sharps Compliance Corp. (NASDAQ:SMED) Popular Amongst Insiders?
Nov 18Does Sharps Compliance (NASDAQ:SMED) Have A Healthy Balance Sheet?
Jul 24Does The Market Have A Low Tolerance For Sharps Compliance Corp.'s (NASDAQ:SMED) Mixed Fundamentals?
Jul 06Gewinn- und Umsatzwachstumsprognosen
| Datum | Umsatz | Gewinne | Freier Cashflow | Bargeld aus operativen Tätigkeiten | Durchschn. Anz. Analysten |
|---|---|---|---|---|---|
| 6/30/2024 | 77 | 5 | 7 | 8 | 1 |
| 6/30/2023 | 65 | 1 | 2 | 4 | 2 |
| 6/30/2022 | 65 | -1 | -6 | -4 | 2 |
| 3/31/2022 | 69 | 4 | 3 | 5 | N/A |
| 12/31/2021 | 79 | 11 | 12 | 14 | N/A |
| 9/30/2021 | 77 | 12 | 15 | 17 | N/A |
| 6/30/2021 | 76 | 13 | 19 | 22 | N/A |
| 3/31/2021 | 70 | 10 | 2 | 7 | N/A |
| 12/31/2020 | 53 | 2 | -3 | 2 | N/A |
| 9/30/2020 | 51 | 1 | -3 | 2 | N/A |
| 6/30/2020 | 51 | 2 | -3 | 1 | N/A |
| 3/31/2020 | 51 | 1 | -2 | 1 | N/A |
| 12/31/2019 | 50 | 1 | -1 | 1 | N/A |
| 9/30/2019 | 48 | 1 | 0 | 1 | N/A |
| 6/30/2019 | 44 | 0 | 0 | 1 | N/A |
| 3/31/2019 | 42 | 0 | 0 | 2 | N/A |
| 12/31/2018 | 42 | 0 | 1 | 2 | N/A |
| 9/30/2018 | 41 | -1 | 1 | 2 | N/A |
| 6/30/2018 | 40 | -1 | 1 | 2 | N/A |
| 3/31/2018 | 41 | 0 | 0 | 1 | N/A |
| 12/31/2017 | 40 | 0 | -1 | 1 | N/A |
| 9/30/2017 | 38 | 0 | -1 | 1 | N/A |
| 6/30/2017 | 38 | -1 | -3 | -1 | N/A |
| 3/31/2017 | 37 | -2 | -3 | 0 | N/A |
| 12/31/2016 | 35 | -2 | -3 | 1 | N/A |
| 9/30/2016 | 35 | -1 | -3 | -1 | N/A |
| 6/30/2016 | 33 | 0 | -1 | 1 | N/A |
| 3/31/2016 | 34 | 1 | -1 | 1 | N/A |
| 12/31/2015 | 33 | 1 | N/A | 1 | N/A |
| 9/30/2015 | 32 | 1 | N/A | 1 | N/A |
Analystenprognosen zum zukünftigen Wachstum
Einkommen vs. Sparrate: SMED's forecast earnings growth (55% per year) is above the savings rate (1.9%).
Ertrag vs. Markt: SMED's earnings (55% per year) are forecast to grow faster than the US market (14.2% per year).
Hohe Wachstumserträge: SMED's earnings are expected to grow significantly over the next 3 years.
Einnahmen vs. Markt: SMED's revenue (5.1% per year) is forecast to grow slower than the US market (7.7% per year).
Hohe Wachstumseinnahmen: SMED's revenue (5.1% per year) is forecast to grow slower than 20% per year.
Wachstumsprognosen für den Gewinn je Aktie
Künftige Eigenkapitalrendite
Künftige Eigenkapitalrendite: Insufficient data to determine if SMED's Return on Equity is forecast to be high in 3 years time